Cassidy, J., Douillard, J., Twelves, C., McKendrick, J., Scheithauer, W., Bustová, I., . . . Garrison, L. (2006). Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: The X-ACT trial.
Cita Chicago (17th ed.)Cassidy, J., et al. Pharmacoeconomic Analysis of Adjuvant Oral Capecitabine Vs Intravenous 5-FU/LV in Dukes' C Colon Cancer: The X-ACT Trial. 2006.
Cita MLA (9th ed.)Cassidy, J., et al. Pharmacoeconomic Analysis of Adjuvant Oral Capecitabine Vs Intravenous 5-FU/LV in Dukes' C Colon Cancer: The X-ACT Trial. 2006.
Atenció: Aquestes cites poden no estar 100% correctes.